EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective

Wayne Eskridge, Donna R Cryer iD, Jörn M Schattenberg, Amalia Gastaldelli iD, Harmeet Malhi, Alina M Allen, Mazen Noureddin, Arun J Sanyal

Journal of Clinical Medicine · 26.09.2023 · 12 (19) · 6216

DOI: 10.3390/jcm12196216 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.09.2023. Verfasst von Wayne Eskridge und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fatty Liver Foundation, Boise, ID 83706, USA. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diagnosing and managing metabolic dysfunction-associated steatotic liver disease (MASLD) remains a major challenge in primary care due to lack of agreement on diagnostic tools, difficulty in identifying symptoms and determining their cause, absence of approved pharmacological treatments, and limited awareness of the disease. However, prompt diagnosis and management are critical to preventing MASLD from progressing to more severe forms of liver disease. This highlights the need to raise awareness and improve understanding of MASLD among both patients and physicians. The patient perspective is invaluable to advancing our knowledge of this disease and how to manage it, as their perspectives have led to the growing recognition that patients experience subtle symptoms and that patient-reported outcomes should be incorporated into drug development. This review and expert opinion examine MASLD and metabolic dysfunction-associated steatohepatitis from the patient and physician perspective from pre-diagnosis to diagnosis and early care, through to progression to advanced liver damage. Specifically, the paper dives into the issues patients and physicians experience, and, in turn, what is required to improve diagnosis and management, including tips and tools to empower patients and physicians dealing with MASLD.

Schlagwörter

Stichwörter der Autor:innen

advocacycirrhosisfatty liverliver diseasemetabolic dysfunction-associated steatohepatitismetabolic dysfunction-associated steatotic liver diseaseoutcomeprimary care physiciansquality of life

Autor:innen und Institutionen

  • Fatty Liver Foundation, Boise, ID 83706, USA.
  • Global Liver Institute, Washington, DC 20016, USA.
  • Metabolic Liver Research Program, Department of Medicine, University Medical Center of the Johannes Gutenberg University, 155131 Mainz, Germany.
  • Cardiometabolic Risk Laboratory, Institute of Clinical Physiology, Italian National Research Council CNR, 00133 Pisa, Italy.
  • Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN 55901, USA.
  • Fatty Liver Program, Karsh Division of Gastroenterology and Hepatology, Cedar Sinai Medical Center, Los Angeles, CA 90048, USA.

ORCID-Profile: Donna R Cryer, Amalia Gastaldelli

Förderung

  • Pfizer Inc

Zitieren

APA

Eskridge, W., Cryer, D. R., Schattenberg, J. M., Gastaldelli, A., Malhi, H., Allen, A. M., Noureddin, M., & Sanyal, A. J. (2023). Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective. Journal of Clinical Medicine, 12(19), 6216. https://doi.org/10.3390/jcm12196216

Vancouver

Eskridge W, Cryer DR, Schattenberg JM, Gastaldelli A, Malhi H, Allen AM, et al. Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective. Journal of Clinical Medicine. 2023;12(19):6216. doi:10.3390/jcm12196216

BibTeX
@article{Eskridge2023,
  author = {Eskridge, Wayne and Cryer, Donna R and Schattenberg, Jörn M and Gastaldelli, Amalia and Malhi, Harmeet and Allen, Alina M and Noureddin, Mazen and Sanyal, Arun J},
  title = {Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {19},
  pages = {6216},
  doi = {10.3390/jcm12196216}
}
Kostenlos starten →